Abekawa T, T Ohmori and T Koyama (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.Brain Res.
Albers DS and PK Sonsalla (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.J. Pharmacol. Exp. Ther.
Ali SF, JL Martin, MD Black and Y Itzhak (1999) Neuroprotective role of melatonin in methamphetamine-and 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity. Ann.NYAcad. Sci.
Alldredge BK, DH Lowenstein and RP Simon (1989) Seizures associated with recreational drug abuse.Neurology
Amato JL, MG Bankson and BK Yamamoto (2006) Prior Exposure to chronic stress and MDMA potentiates meso-accumbens dopamine release mediated by the 5-HT(1B) receptor.Neuropsychopharmacology 2006 Aug 2; [Epub ahead of print].
Asanuma M, T Hayashi, SV Ordonez, N Ogawa and JL Cadet (2000) Direct interactions of methamphetamine with the nucleus.Brain Res. Mol.Brain Res.
Asanuma M, T Tsuji, I Miyazaki, K Miyoshi and N Ogawa (2003) Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug.Neurosci. Lett.
Atlante A, P Calissano, A Bobba, S Giannattasio, E Marra and S Passarella (2001) Glutamate neurotoxicity, oxidative stress and mitochondria.FEBS Lett.
Augsburger M, N Donze, A Menetrey, C Brossard, F Sporkert, C Giroud and P Mangin (2005) Concentration of drugs in blood of suspected impaired drivers.Forensic Sci. Int.
Baker A and T Meert (2003) Morphine and d-amphetamine nullify each others’ hypothermic effects in mice.Pharmacol. Toxicol.
Baldwin HA, MI Colado, TK Murray, RJ De Souza and AR Green (1993) Striatal dopamine releasein vivo
following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.Br. J. Pharmacol.
Bankson MG and KA Cunningham (2001) 3,4-Methylenedio xymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.J. Pharmacol. Exp. Ther.
Barnhart BC, EC Alappat and ME Peter (2003) The CD95 type I/type H model.Semin. Immunol.
Bartu A, NC Freeman, GS Gawthorne, JP Codde and CD Holman (2004) Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia.Addiction
Battaglia G, SY Yeh, E O’Hearn, ME Molliver, MJ Kuhar and EB De Souza (1987) 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3
H]paroxetine-labeled serotonin uptake sites.J. Pharmacol. Exp. Ther.
Battaglia G, SY Yeh and EB De Souza (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.Pharmacol. Biochem. Behav.
Battaglia G, F Fornai, CL Busceti, G Aloisi, F Cerrito, A De Blasi, D Melchiorri and F Nicoletti (2002) Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.J. Neurosci.
Berger UV, XF Gu, JW van Lange and EC Azmitia (1992) Evidence for a common mechanism of serotonin release induced by substituted amphetaminesin vitro
.Ann. NY Acad. Sci.
Betts ES, IN Krasnova, MT McCoy, B Ladenheim and JL Cadet (2002) Analysis of methamphetamine-induced changes in the expression of integrin family members in the cortex of wild-type and c-fos knockout mice.Neurotox. Res.
Bolla KI, UD McCann and GA Ricaurte (1998) Memory impairment in abstinent MDMA (‘Ecstasy’) users.Neurology
Bowyer JF, DL Davies, L Schmued, HW Broening, GD Newport, W Slikker Jr and RR Holson (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity.J. Pharmacol. Exp. Ther.
Brown TN, J Schulenberg, JG Bachman, PM O’Malley and LD Johnston (2001) Are risk and protective factors for substance use consistent across historical time?: national data from the high school classes of 1976 through 1997.Prev. Sci.
Buchert R, J Obrocki, R Thomasius, O Vaterlein, K Petersen, L Jenicke, KH Bohuslavizki and M Clausen (2001) Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PET.Nucl. Med. Commun.
Buffenstein A, J Heaster and P Ko (1999) Chronic psychotic illness from methamphetamine.Am. J. Psychiatry
Cadet JL and C Brannock (1998) Free radicals and the pathobiology of brain dopamine systems.Neurochem. Int.
Cadet JL, S Ali and C Epstein (1994a) Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice.Ann. NY Acad. Sci.
Cadet JL, B Ladenheim, I Baum, E Carlson and C Epstein (1994b) CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylene-dioxyamphetamine (MDA) and of methylenedioxymetham-phetamine (MDMA).Brain Res.
Cadet JL, B Ladenheim, H Hirata, RB Rothman, S Ali, E Carlson, C Epstein and TH Moran (1995) Superoxide radicals mediate the biochemical effects of methylene-dioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice.Synapse
Cadet JL,SV Ordonezand and JV Ordonez(1997)Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2.Synapse
Cadet JL, S Jayanthi, MT McCoy, M Vawter and B Ladenheim (2001) Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array.Synapse
Cadet JL, MT McCoy and B Ladenheim (2002) Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: evidence from cDNA array analyses.Synapse
Cadet JL, S Jayanthi and X Deng (2003) Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis.FASEB J.
Cadet JL, S Jayanthi and X Deng (2005) Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review.Neurotox. Res.
Callahan BT, BJ Cord, J Yuan, UD McCann and GA Ricaurte (2001) Inhibitors of Na(+)/H(+) and Na(+)/Ca(2+) exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity.J. Neurochem.
Callaway CW and RF Clark (1994) Hyperthermia in psycho- stimulant overdose.Ann. Emerg. Med.
Cho AK and WP Melega (2002) Patterns of methamphetamine abuse and their consequences.J. Addict. Dis.
Choi C and EN Benveniste (2004) Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses.Brain Res. Brain Res. Rev.
Chowdhury I, B Tharakan and GK Bhat (2006) Current concepts in apoptosis: the physiological suicide program revisited.Cell. Mol. Biol. Lett.
Chung KK, TM Dawson and VL Dawson (2005) Nitric oxide, S-nitrosylation and neurodegeneration.Cell Mol. Biol. (Noisy-le-grand)
Chynn KY (1968) Technique for experimental embolization of cerebral arteries and repetitive selective internal carotid arteriography in dogs.Invest. Radiol.
Clausing P and JF Bowyer (1999) Time course of brain temperature and caudate/putamen microdialysate levels of amphetamine and dopamine in rats after multiple doses of d-amphetamine.Ann. NY Acad. Sci.
Clausing P, B Gough, RR Holson, W Slikker Jr and JF Bowyer (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.J. Pharmacol. Exp. Ther.
Colado MI and AR Green (1994) A study of the mechanism of MDMA (‘ecstasy’)-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.Br. J. Pharmacol.
Colado MI and AR Green (1995) The spin trap reagent alpha- phenyl-N-tert-butyl nitrone prevents ‘ecstasy’-induced neurodegeneration of 5-hydroxytryptamine neurones.Eur. J. Pharmacol.
Colado MI, TK Murray and AR Green (1993) 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.Br. J. Pharmacol.
Commins DL, G Vosmer, RM Virus, WL Woolverton, CR Schuster and LS Seiden (1987) Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.J. Pharmacol. Exp. Ther.
Craig AL and HJ Kupferberg (1972) Hyperthermia in damphetamine toxicity in aggregated mice of different strains.J. Pharmacol. Exp. Ther.
Cubells JF, S Rayport, G Rajendran and D Sulzer (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.J. Neurosci.
Culmsee C and MP Mattson (2005) p53 in neuronal apoptosis.Biochem. Biophys. Res. Commun.
Dafters RI (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.Physiol. Behav.
Dafters RI and E Lynch (1998) Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphet-amine (MDMA or “Ecstasy”) but not by fenfluramine.Psychopharmacology (Berl.)
Dalton TP, HG Shertzer and A Puga (1999) Regulation of gene expression by reactive oxygen.Annu. Rev. Pharmacol. Toxicol.
Dawson VL and TM Dawson (1998) Nitric oxide in neurode-generation.Prog. Brain Res.
De Letter EA, MH Piette, WE Lambert and JA Cordonnier (2006) Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976-2004.Med. Sci. Law
De Souza EB, G Battaglia and TR Insel (1990) Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies.Ann. NY Acad. Sci.
, 682–697; discussion 697-688.PubMed
De Vito MJ and GC Wagner (1989) Methamphetamine- induced neuronal damage: a possible role for free radicals.Neuropharmacology
Deng X and JL Cadet (2000) Methamphetamine-induced apoptosis is attenuated in the striata of copper-zinc superoxide dismutase transgenic mice.Brain Res. Mol. Brain Res.
Deng X, B Ladenheim, LI Tsao and JL Cadet (1999) Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity.J. Neurosci.
Deng X, Y Wang, J Chou and JL Cadet (2001) Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method.Brain Res. Mol. Brain Res.
Deng X, NS Cai, MT McCoy, W Chen, MA Trush and JL Cadet (2002a) Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway.Neuropharmacology
Deng X, S Jayanthi, B Ladenheim, IN Krasnova and JL Cadet (2002b) Mice with partial deficiency of c-Jun show attenuation of methamphetamine-induced neuronal apoptosis.Mol. Pharmacol.
Derlet RW, P Rice, BZ Horowitz and RV Lord (1989) Amphetamine toxicity: experience with 127 cases.J. Emerg. Med.
Dore G and M Sweeting (2006) Drug-induced psychosis associated with crystalline methamphetamine.Australas Psychiatry
Droin NM, MJ Pinkoski, E Dejardin and DR Green (2003) Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses.Mol. Cell. Biol.
Eisch AJ and JF Marshall (1998) Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury.Synapse
Ellison G, MS Eison, HS Huberman and F Daniel (1978) Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration.Science
Farfel GM and LS Seiden (1995) Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphet-amine, fenfluramine, dizocilpine and dextromethorphan.J. Pharmacol. Exp. Ther.
Farfel GM, GL Vosmer and LS Seiden (1992) The N-methyl- D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylene- dioxymethamphetamine and p-chloroamphetamine.Brain Res.
Farrell M, J Marsden, R Ali and W Ling (2002) Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region.Addiction
Ferguson SM, CS Norton, SJ Watson, H Akil and TE Robinson (2003) Amphetamine-evoked c-fos mRNA expression in the caudate-putamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context.J. Neurochem.
Ferri KF and G Kroemer (2001) Organelle-specific initiation of cell death pathways.Nat. Cell. Biol.
Fischer C, G Hatzidimitriou, J Wlos, J Katz and G Ricaurte (1995) Reorganization of ascending 5-HT axon projec- tions in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”).J. Neurosci.
Fukami G, K Hashimoto, K Koike, N Okamura, E Shimizu and M Iyo (2004) Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.Brain Res.
Fumagalli F, RR Gainetdinov, KJ Valenzano and MG Caron (1998) Role of dopamine transporter in methamphetamine- induced neurotoxicity: evidence from mice lacking the transporter.J. Neurosci.
Gerra G, A Zaimovic, M Ferri, U Zambelli, M Timpano, E Neri, GF Marzocchi, R Delsignore and F Brambilla (2000) Long- lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.Biol. Psychiatry
Gilcrease MZ (2007) Integrin signaling in epithelial cells.Cancer Lett.
Ginsberg MD, M Hertzman and WW Schmidt-Nowara (1970) Amphetamine intoxication with coagulopathy, hyperther-mia, and reversible renal failure. A syndrome resembling heatstroke.Ann. Intern. Med.
Gluck MR, LY Moy, E Jayatilleke, KA Hogan, L Manzino and PK Sonsalla (2001) Parallel increases in lipid and protein oxidative markers in several mouse brain regions after meth- amphetamine treatment.J. Neurochem.
Gordon CJ, WP Watkinson, JP O’Callaghan and DB Miller (1991) Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat.Pharmacol. Biochem. Behav.
Gudelsky GA and JF Nash (1996) Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.J. Neurochem.
Gustavsen I, J Morland and JG Bramness (2006) Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers.Accid. Anal. Prev.
Harold C, T Wallace, R Friedman, G Gudelsky and B Yamamoto (2000) Methamphetamine selectively alters brain glutathione.Eur. J. Pharmacol.
Hatzidimitriou G, UD McCann and GA Ricaurte (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphet-amine seven years previously: factors influencing abnormal recovery.J. Neurosci.
Hirata H, B Ladenheim, E Carlson, C Epstein and JL Cadet (1996) Autoradiographic evidence for methamphetamine- induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.Brain Res.
Hsieh P (2001) Molecular mechanisms of DNA mismatch repair.Mutat. Res.
Huang NK, FJ Wan, CJ Tseng and CS Tung(1997) Amphetamine induces hydroxyl radical formation in the striatum of rats.Life Sci.
Hughes PE, T Alexi, CE Williams, RG Clark and PD Gluckman (1999) Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington’s disease.Neuroscience
Imai Y and S Kohsaka (2002) Intracellular signaling in M-CSF-induced microglia activation: role of Iba1.Glia
Imam SZ and SF Ali (2000) Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation.Brain Res.
Imam SZ, GD Newport, Y Itzhak, JL Cadet, F Islam, W Slikker Jr and SF Ali (2001) Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase.J. Neurochem.
Insel TR, G Battaglia, JN Johannessen, S Marra and EB De Souza (1989) 3,4-Methylenedioxymethamphetamine (“ecstasy”) selectively destroys brain serotonin terminals in rhesus monkeys.J. Pharmacol. Exp. Ther.
Itzhak Y and SF Ali (2006) Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs.Pharmacol. Ther.
Itzhak Y, C Gandia, PL Huang and SF Ali (1998) Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.J. Pharmacol. Exp. Ther.
Itzhak Y, JL Martin and SF Ali (2000) nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice.Neuroreport
Iversen L (2006) Neurotransmitter transporters and their impact on the development of psychopharmacology.Br. J. Pharmacol.
147 Suppl. 1, S82-S88.
Jakab RL and JF Bowyer (2002) Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke.Brain Res.
Janowsky DS and C Risch (1979) Amphetamine psychosis and psychotic symptoms.Psychopharmacology (Berl.)
Jayanthi S, B Ladenheimand JL Cadet (1998) Methamphetamine- induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice.Ann. NYAcad. Sci.
Jayanthi S, B Ladenheim, AM Andrews and JL Cadet (1999) Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (ecstasy).Neuroscience
Jayanthi S, X Deng, M Bordelon, MT McCoy and JL Cadet (2001) Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex.FASEBJ.
Jayanthi S, X Deng, PA Noailles, B Ladenheim and JL Cadet (2004) Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochon- dria-dependent death cascades.FASEBJ.
Jayanthi S, X Deng, B Ladenheim, MT McCoy, A Cluster, NS Cai and JL Cadet (2005) Calcineurin/NFAT-induced up- regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis.Proc. Natl. Acad. Sci. USA
Johnson M, GR Hanson and JW Gibb (1989) Effect of MK- 801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog.Eur. J. Pharmacol.
Jones AW (2005) Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances.Traffic Inj. Prev.
Jori A and M Rutczynski (1978) A genetic analysis of the hyperthermic response to d-amphetamine in two inbred strains of mice.Psychopharmacology (Berl.)
Kalant H and OJ Kalant (1975) Death in amphetamine users: causes and rates.Can. Med. Assoc. J.
Kil HY, J Zhang and CA Piantadosi (1996) Brain temperature alters hydroxyl radical production during cerebral isch- emia/reperfusion in rats.J. Cereb. Blood Flow Metab.
Kish SJ, Y Furukawa, L Ang, SP Vorce and KS Kalasinsky (2000) Striatal serotonin is depleted in brain of a human MDMA (ecstasy) user.Neurology
Kondo T, T Ito and Y Sugita (1994) Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum.Ann. NY Acad. Sci.
Kostowski W, A Plaznik, O Pucilowski and E Malatynska (1982) Effect of lesions of the brain noradrenergic systems on amphetamine-induced hyperthermia and locomotor stimulation.Acta Physiol. Pol.
Krasnova IN, B Ladenheim, S Jayanthi, J Oyler, TH Moran, MA Huestis and JL Cadet (2001) Amphetamine-induced toxicity in dopamine terminals in CD-1 and C57BL/6J mice: complex roles for oxygen-based species and temperature regulation.Neuroscience
Krasnova IN, MT McCoy, B Ladenheim and JL Cadet (2002) cDNA array analysis of gene expression profiles in the stri- ata of wild-type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine.FASEB J.
Krasnova IN, B Ladenheim and JL Cadet (2005) Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway.FASEB J.
Krieglstein K, C Suter-Crazzolara, WH Fischer and K Unsicker (1995) TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity.EMBOJ.
Ladeby R, M Wirenfeldt, D Garcia-Ovejero, C Fenger, L Dissing-Olesen, I Dalmau and B Finsen (2005) Microglial cell population dynamics in the injured adult central nervous system.Brain Res. Brain Res. Rev.
Lan KC, YF Lin, FC Yu, CS Lin and P Chu (1998) Clinical manifestations and prognostic features of acute methamphet-amine intoxication.J. Formos. Med. Assoc.
LaVoie MJ and TG Hastings (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.J. Neurosci.
LaVoie MJ, JP Card and TG Hastings (2004) Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity.Exp. Neurol.
Levine AS, DC Jewett, JP Cleary, CM Kotz and CJ Billington (2004) Our journey with neuropeptide Y: effects on ingestive behaviors and energy expenditure.Peptides
Lew R, KE Sabol, C Chou, GL Vosmer, J Richards and LS Seiden (1996) Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradi-ography studies.J. Pharmacol. Exp. Ther.
Li Y and MA Trush (1993) DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation.Carcinogenesis
Li-Weber M and PH Krammer (2002) The death of a T-cell: expression of the CD95 ligand.Cell Death Differ.
Li-Weber M, O Laur and PH Krammer (1999) Novel Egr/NF- AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation.Eur. J. Immunol.
Liechti ME, C Baumann, A Gamma and FX Vollenweider (2000) Acute psychological effects of 3,4-methyl- enedioxymethamphetamine (MDMA, “ecstasy”) are attenuated by the serotonin uptake inhibitor citalopram.Neuropsychopharmacology
Lin PS, S Quamo, KC Ho and J Gladding (1991) Hyperthermia enhances the cytotoxic effects of reactive oxygen species to Chinese hamster cells and bovine endothelial cellsin vitro
Locksley RM, N Killeen and MJ Lenardo (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology.Cell
Lombard DB, KF Chua, R Mostoslavsky, S Franco, M Gostissa and FW Alt (2005) DNA repair, genome stability, and aging.Cell
London ED, SL Simon, SM Berman, MA Mandelkern, AM Lichtman, J Bramen, AK Shinn, K Miotto, J Learn, Y Dong, JA Matochik, V Kurian, T Newton, R Woods, R Rawson and W Ling (2004) Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.Arch. Gen. Psychiatry
Lotharius J and KL O’Malley (2001) Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity.Ann. Neurol.
Lyles J and JL Cadet (2003) Methylenedioxymeth-amphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms.Brain Res. Brain Res. Rev.
Macario AJ and E Conway de Macario (2005) Sick chaperones, cellular stress, and disease.N. Engl. J. Med.
Malberg JE, KE Sabol and LS Seiden (1996) Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.J. Pharmacol. Exp. Ther.
Mark KA, JJ Soghomonian and BK Yamamoto (2004) High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.J. Neurosci.
Marshall JF, SJ O’Dell and FB Weihmuller (1993) Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity.J. Neural Transm. Gen. Sect.
Martin SS and K Vuori (2004) Regulation of Bcl-2 proteins during anoikis and amorphosis.Biochim. Biophys. Acta
Matthews RT, TH Champney and GD Frye (1989) Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats.Pharmacol. Biochem. Behav.
McCabe SE, CJ Teter and CJ Boyd (2004) The use, misuse and diversion of prescription stimulants among middle and high school students.Subst. Use Misuse
McCabe SE, JR Knight, CJ Teter and H Wechsler (2005) Non- medical use of prescription stimulants among US college students: prevalence and correlates from a national survey.Addiction
McCann UD, A Ridenour, Y Shaham and GA Ricaurte (1994) Serotonin neurotoxicity after (+/-)3,4-methylenedioxymeth- amphetamine (MDMA; “ecstasy”): a controlled study in humans.Neuropsychopharmacology
McCann UD, Z Szabo, U Scheffel, RF Dannals and GA Ricaurte (1998a) Positron emission tomographic evidence of toxic effect of MDMA (“ecstasy”) on brain serotonin neurons in human beings.Lancet
McCann UD, DF Wong, F Yokoi, V Villemagne, RF Dannals and GA Ricaurte (1998b) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathi-none users: evidence from positron emission tomography studies with [11C]WIN-35,428.J. Neurosci.
McCann UD, M Mertl, V Eligulashvili and GA Ricaurte (1999) Cognitive performance in (+/-) 3,4-methylenedioxymeth-amphetamine (MDMA, “ecstasy”) users: a controlled study.Psychopharmacology (Berl.)
McCann UD, V Eligulashvili and GA Ricaurte (2000) (+/-)3,4- Methylenedioxymethamphetamine (“ecstasy”)-induced serotonin neurotoxicity: clinical studies.Neuropsychobiology
McCullough KD, JL Martindale, LO Klotz, TY Aw and NJ Holbrook (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state.Mol. Cell. Biol.
McKenna DJ and SJ Peroutka (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”).J. Neurochem.
McKetin R and RP Mattick (1997) Attention and memory in illicit amphetamine users.Drug Alcohol Depend.
Mechan AO, B Esteban, E O’Shea, JM Elliott, MI Colado and AR Green (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylene-dioxymethamphetamine (MDMA, ‘ecstasy’) to rats.Br. J. Pharmacol.
Milanovic D, V Pesic, L Rakic, S Kanazir and S Ruzdijic (2006) Enhancement of AP-1 DNA-binding activity during amphetamine- and phencyclidine-mediated behaviour in rats.Neuropharmacology
Miller DB and JP O’Callaghan (1994) Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.J. Pharmacol. Exp. Ther.
Miller DB and JP O’Callaghan (1996) Neurotoxicity of damphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system.Ann. NYAcad. Sci.
Mills EM, ML Banks, JE Sprague and T Finkel (2003) Pharmacology: uncoupling the agony from ecstasy.Nature
Miyazaki I, M Asanuma, FJ Diaz-Corrales, M Fukuda, K Kitaichi, K Miyoshi and N Ogawa (2006) Methamphet-amine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.FASEB J.
Moll UM, S Wolff, D Speidel and W Deppert (2005) Transcription-independent pro-apoptotic functions of p53.Curr. Opin. Cell. Biol.
Molliver ME, UV Berger, LA Mamounas, DC Molliver, E O’Hearn and MA Wilson (1990) Neurotoxicity of MDMA and related compounds: anatomic studies.Ann. NY Acad. Sci.
, 649–661; discussion 661-644.PubMed
Murachi T, K Tanaka, M Hatanaka and T Murakami (1980) Intracellular Ca2+
-dependent protease (calpain) and its high- molecular-weight endogenous inhibitor (calpastatin).Adv. Enzyme Regul.
Murray JB (1998) Psychophysiological aspects of amphet-amine-methamphetamine abuse.J. Psychol.
Nagata S (1999) Fas ligand-induced apoptosis.Annu. Rev. Genet.
Nakagawa T and J Yuan (2000) Cross-talk between two cyste- ine protease families. Activation of caspase-12 by calpain in apoptosis.J. Cell. Biol.
Nash JFJr, HY Meltzer and GA Gudelsky (1988) Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphet- amine.J. Pharmacol. Exp. Ther.
Nilsen H and HE Krokan (2001) Base excision repair in a network of defense and tolerance.Carcinogenesis
O’Dell SJ and JF Marshall (2000) Repeated administration of methamphetamine damages cells in the somatosensory cortex: overlap with cytochrome oxidase-rich barrels.Synapse
O’Hearn E, G Battaglia, EB De Souza, MJ Kuhar and ME Molliver (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.J. Neurosci.
O’Shea E, I Escobedo, L Orio, V Sanchez, M Navarro, AR Green and MI Colado (2005) Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accum- bens of rats.Neuropsychopharmacology
Oliveira MT, AC Rego, MT Morgadinho, TR Macedo and CR Oliveira (2002) Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells.Ann. NY Acad. Sci.
Ornstein TJ, JL Iddon, AM Baldacchino, BJ Sahakian, M London, BJ Everitt and TW Robbins (2000) Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.Neuropsychopharmacology
Papp E, G Nardai, C Soti and P Csermely (2003) Molecular chaperones, stress proteins and redox homeostasis.Biofactors
Paris JM and KA Cunningham (1992) Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methy-lenedioxymethamphetamine (MDMA).Brain Res. Bull.
Paschen W (2001) Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states.Cell Calcium
Persico AM, CW Schindler, R Zaczek, MT Brannock and GR Uhl (1995) Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress.Synapse
Petit C and A Sancar (1999) Nucleotide excision repair: from E. coli to man.Biochimie
Poli G, G Leonarduzzi, F Biasi and E Chiarpotto (2004) Oxidative stress and cell signalling.Curr. Med. Chem.
Price LH, GA Ricaurte, JH Krystal and GR Heninger (1989) Neuroendocrine and mood responses to intravenous L-tryp-tophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.Arch. Gen. Psychiatry
Puder KS, DV Kagan and JP Morgan (1988) Illicit metham-phetamine: analysis, synthesis, and availability.Am. J. Drug Alcohol Abuse
Qiu J, MJ Whalen, P Lowenstein, G Fiskum, B Fahy, R Darwish, B Aarabi, J Yuan and MA Moskowitz (2002) Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans.J. Neurosci.
Raes E and AG Verstraete (2005) Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID).J Anal. Toxicol.
Raivich G (2005) Like cops on the beat: the active role of resting microglia.Trends Neurosci.
Ravagnan L, T Roumier and G Kroemer (2002) Mitochondria, the killer organelles and their weapons.J. Cell. Physiol.
Reneman L, J Lavalaye, B Schmand, FA de Wolff, W van den Brink, GJ den Heeten and J Booij (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”): preliminary findings.Arch. Gen. Psychiatry
Ricaurte GA, CR Schuster and LS Seiden (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study.Brain Res.
Ricaurte GA, LE De Lanney, SG Wiener, I Irwin and JW Langston (1988a) 5-Hydroxyindoleacetic acid in cerebro-spinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates.Brain Res.
Ricaurte GA, LS Forno, MA Wilson, LE De Lanney, I Irwin, ME Molliver and JW Langston (1988b) (+/-)3,4-Methylene dioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.JAMA
Ricaurte GA, KT Finnegan, I Irwin and JW Langston (1990) Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.Ann. NY. Acad. Sci.
, 699–708; discussion 708-710.PubMed
Ricaurte GA, UD McCann, Z Szabo and U Scheffel (2000) Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’).Toxicol. Lett.
Richard D (1995) Exercise and the neurobiological control of food intake and energy expenditure.Int. J. Obes. Relat. Metab. Disord.
19 Suppl. 4, S73–79.
Rock RB, G Gekker, S Hu, WS Sheng, M Cheeran, JR Lokensgard and PK Peterson (2004) Role of microglia in central nervous system infections.Clin. Microbiol. Rev.
Rogers RD, BJ Everitt, A Baldacchino, AJ Blackshaw, R Swainson, K Wynne, NB Baker, J Hunter, T Carthy, E Booker, M London, JF Deakin, BJ Sahakian and TW Robbins (1999) Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and trypto-phan-depleted normal volunteers: evidence for monoaminergic mechanisms.Neuropsychopharmacology
Sabol KE, R Lew, JB Richards, GL Vosmer and LS Seiden (1996) Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52- week period. Part I: Synaptosomal uptake and tissue concentrations.J. Pharmacol. Exp. Ther.
Salanova V and R Taubner (1984) Intracerebral haemorrhage and vasculitis secondary to amphetamine use.Postgrad. Med. J.
Sanchez C (1989) The effects of dopamine D-1 and D-2 receptor agonists on body temperature in male mice.Eur. J. Pharmacol.
Sanchez V, M Zeini, J Camarero, E O’Shea, L Bosca, AR Green and MI Colado (2003) The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum.J. Neurochem.
Sapp E, KB Kegel, N Aronin, T Hashikawa, Y Uchiyama, K Tohyama, PG Bhide, JP Vonsattel and M DiFiglia (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain.J. Neuropathol. Exp. Neurol.
Scanzello CR, G Hatzidimitriou, AL Martello, JL Katz and GA Ricaurte (1993) Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.J. Pharmacol. Exp. Ther.
Scheffel U, C Steinert, SE Kim, MD Ehlers, JW Boja and MJ Kuhar (1996) Effect of dopaminergic drugs on thein vivo
binding of [3
H]WIN 35,428 to central dopamine transporters.Synapse
Scheffel U, Z Szabo, WB Mathews, PA Finley, RF Dannals, HT Ravert, K Szabo, J Yuan and GA Ricaurte (1998)In vivo
detection of short- and long-term MDMA neurotoxicity - a positron emission tomography study in the living baboon brain.Synapse
Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.J. Pharmacol. Exp. Ther.
Schmidt CJ (1989) Acute and long-term neurochemical effects of methylenedioxymethamphetamine in the rat.NIDA Res. Monogr.
Schmidt CJ and JH Kehne (1990) Neurotoxicity of MDMA: neurochemical effects. Ann.NY Acad. Sci.
600, 665–680; discussion 680-681.
Schmidt CJ, L Wu and W Lovenberg (1986) Methylenediox ymethamphetamine: a potentially neurotoxic amphetamine analogue.Eur. J. Pharmacol.
Schmidt CJ, JA Levin and W Lovenberg (1987)In vitro
neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.Biochem. Pharmacol
Schmidt CJ, CK Black and VL Taylor (1990) Antagonism of the neurotoxicity due to a single administration of methy-lenedioxymethamphetamine.Eur. J. Pharmacol.
Schwartz K, A Weizman and M Rehavi (2006) The effect of psychostimulants on [3
H]dopamine uptake and release in rat brain synaptic vesicles.J. Neural Transm.
Seale TW, JM Carney, P Johnson and OM Rennert (1985) Inheritance of amphetamine-induced thermoregulatory responses in inbred mice.Pharmacol. Biochem. Behav.
Seiden LS, KE Sabol and GA Ricaurte (1993) Amphetamine: effects on catecholamine systems and behavior.Annu. Rev. Pharmacol. Toxicol.
Sekine Y, M Iyo, Y Ouchi, T Matsunaga, H Tsukada, H Okada, E Yoshikawa, M Futatsubashi, N Takei and N Mori (2001) Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.Am. J. Psychiatry
Sekine Y, Y Minabe, Y Ouchi, N Takei, M Iyo, K Nakamura, K Suzuki, H Tsukada, H Okada, E Yoshikawa, M Futatsubashi and N Mori (2003) Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.Am. J. Psychiatry
Sekine Y, Y Ouchi, N Takei, E Yoshikawa, K Nakamura, M Futatsubashi, H Okada, Y Minabe, K Suzuki, Y Iwata, KJ Tsuchiya, H Tsukada, M Iyo and N Mori (2006) Brain serotonin transporter density and aggression in abstinent meth-amphetamine abusers.Arch. Gen. Psychiatry
Semple DM, KP Ebmeier, MF Glabus, RE O’Carroll and EC Johnstone (1999) Reducedin vivo
binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users.Br. J. Psychiatry
Shankaran M and GA Gudelsky (1998) Effect of 3,4-meth-ylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin.Pharmacol. Biochem. Behav.
Sheng P, C Cerruti, S Ali and JL Cadet (1996) Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity.In vitro evidence from primary cultures of mesencephalic cells.Ann. NYAcad. Sci.
Silva OA and M Yonamine (2004) Drug abuse among workers in Brazilian regions.Rev. Saude Publica
Simantov R and M Tauber (1997) The abused drug MDMA (ecstasy) induces programmed death of human serotonergic cells.FASEB J.
Simon SL, C Domier, J Carnell, P Brethen, R Rawson and W Ling (2000) Cognitive impairment in individuals currently using methamphetamine.Am. J. Addict.
Slikker W Jr, SF Ali, AC Scallet, CH Frith, GD Newport and JR Bailey (1988) Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).Toxicol. Appl. Pharmacol.
Smith LM, LL LaGasse, C Derauf, P Grant, R Shah, A Arria, M Huestis, W Haning, A Strauss, SD Grotta, J Liu and BM Lester (2006) The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth.Pediatrics
Sonsalla PK, WJ Nicklas and RE Heikkila (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.Science
Sprague JE and DE Nichols (1995) Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum.Psychopharmacology (Berl.)
Sprague JE, ML Banks, VJ Cook and EM Mills (2003) Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy).J. Pharmacol. Exp. Ther.
Sprague JE, P Moze, D Caden, DE Rusyniak, C Holmes, DS Goldstein and EM Mills (2005) Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) in an animal model.Crit. Care Med.
Sriram K, DB Miller and JP O’Callaghan (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha.J. Neurochem.
Steentoft A, B Teige, P Holmgren, E Vuori, J Kristinsson, AC Hansen, G Ceder, G Wethe and D Rollmann (2006) Fatal poisoning in Nordic drug addicts in 2002.Forensic Sci. Int.
Stewart VC, AJ Heslegrave, GC Brown, JB Clark and SJ Heales (2002) Nitric oxide-dependent damage to neuronal mitochondria involves the NMD A receptor.Eur. J. Neurosci.
Stokes AH, TG Hastings and KE Vrana (1999) Cytotoxic and genotoxic potential of dopamine.J. Neurosci. Res.
Stone DM, DC Stahl, GR Hanson and JW Gibb (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on mono-aminergic systems in the rat brain.Eur. J. Pharmacol.
Stone DM, KM Merchant, GR Hanson and JW Gibb (1987) Immediate and long-term effects of 3,4-methylenedioxy-methamphetamine on serotonin pathways in brain of rat.Neuropharmacology
Stumm G, J Schlegel, T Schafer, C Wurz, HD Mennel, JC Krieg and H Vedder (1999) Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons.FASEB J.
Sulzer D, TK Chen, YY Lau, H Kristensen, S Rayport and A Ewing (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.J. Neurosci.
Taraska T and KT Finnegan (1997) Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxy-methamphetamine.J. Pharmacol. Exp. Ther.
Thiriet N, B Ladenheim, MT McCoy and JL Cadet (2002) Analysis of ecstasy (MDMA)-induced transcriptional responses in the rat cortex.FASEB J.
Thiriet N, X Deng, M Solinas, B Ladenheim, W Curtis, SR Goldberg, RD Palmiter and JL Cadet (2005) Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum.J. Neurosci.
Thomas DM and DM Kuhn (2005) MK-801 and dextro-methorphan block microglial activation and protect against methamphetamine-induced neurotoxicity.Brain Res.
Thomas DM, J Dowgiert, TJ Geddes, D Francescutti-Verbeem, X Liu and DM Kuhn (2004) Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.Neurosci. Lett.
Verma A and SK Kulkarni (1993) Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats.Arch. Int. Pharmacodyn. Ther.
Volkow ND, L Chang, GJ Wang, JS Fowler, D Franceschi, MJ Sedler, SJ Gatley, R Hitzemann, YS Ding, C Wong and J Logan (2001a) Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.Am. J. Psychiatry
Volkow ND, L Chang, GJ Wang, JS Fowler, M Leonido-Yee, D Franceschi, MJ Sedler, SJ Gatley, R Hitzemann, YS Ding, J Logan, C Wong and EN Miller (2001b) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.Am. J. Psychiatry
Wagner GC, GA Ricaurte, CE Johanson, CR Schuster and LS Seiden (1980a) Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate.Neurology
Wagner GC, GA Ricaurte, LS Seiden, CR Schuster, RJ Miller and J Westley (1980b) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.Brain Res.
Wagner GC, RM Carelli and MF Jarvis (1985) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats.Res. Commun. Chem. Pathol. Pharmacol.
Wan FJ, HC Lin, YS Lin and CJ Tseng (2000) Intra-striatal infusion of D-amphetamine induces hydroxyl radical formation: inhibition by MK-801 pretreatment.Neuropharmacology
Werner S and C Alzheimer (2006) Roles of activin in tissue repair, fibrosis, and inflammatory disease.Cytokine Growth Factor Rev.
White SR, T Obradovic, KM Imel and MJ Wheaton (1996) The effects of methylenedioxymethamphetamine (MDMA, “ecstasy”) on monoaminergic neurotransmission in the central nervous system.Prog. Neurobiol.
Wieloch T and K Nikolich (2006) Mechanisms of neural plasticity following brain injury.Curr. Opin. Neurobiol.
Wilson JM, KS Kalasinsky, AI Levey, C Bergeron, G Reiber, RM Anthony, GA Schmunk, K Shannak, JW Haycock and SJ Kish (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.Nat. Med.
Wylie FM, H Torrance, A Seymour, S Buttress and JS Oliver (2005) Drugs in oral fluid. Part II. Investigation of drugs in drivers.Forensic Sci. Int.
Xiang Z, V Haroutunian, L Ho, D Purohit and GM Pasinetti (2006) Microglia activation in the brain as inflammatory biomarker of Alzheimer’s disease neuropathology and clinical dementia.Dis. Markers
Yeh SY and FL Hsu (1991) The neurochemical and stimulatory effects of putative metabolites of 3,4-methylene-dioxyamphetamine and 3,4-methylenedioxymethamphet-amine in rats.Pharmacol. Biochem. Behav.
Yui K, K Goto, S Ikemoto, T Ishiguro, B Angrist, GE Duncan, BB Sheitman, JA Lieberman, SH Bracha and SF Ali (1999) Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization.Mol. Psychiatry
Zafar KS, D Siegel and D Ross (2006) A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition.Mol. Pharmacol.
Zarrindast MR and SA Tabatabai (1992) Involvement of dopamine receptor subtypes in mouse thermoregulation.Psychopharmacology (Berl.)
Zinszner H, M Kuroda, X Wang, N Batchvarova, RT Lightfoot, H Remotti, JL Stevens and D Ron (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum.Genes Dev.